Posts by NextStep
Our Monthly Scientific Selection: April Publications on EuroQol Instruments
[1-30 April 2024]
Read MoreOur Monthly Scientific Selection: March Publications on EuroQol Instruments
[1-31 March 2024] 1. Xie F, Xie S, Pullenayegum E, Ohinmaa A. Understanding Canadian stakeholders’ views on measuring and valuing health for children and adolescents: a qualitative study. Qual Life Res. 2024 Mar 5. 2. Cheng LJ, Pan T, Chen LA, Cheng JY, Mulhern B, Devlin N, Luo N. The Ceiling Effects of EQ-5D-3L and…
Read MoreOur Monthly Scientific Selection: February Publications on EuroQol Instruments
[1-29 February 2024] 1. Lipman SA, Reckers-Droog VT. Comparing heuristic valuation processes between health state valuation from child and adult perspectives. Eur J Health Econ. 2024 Feb 3. 2. O’Loughlin R, Jones R, Chen G, Mulhern B, Hiscock H, Devlin N, Dalziel K. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments…
Read MoreNew Members joined the EuroQol Group Association
In 2024, four new members have joined the EuroQol Group Association. Congratulations! Rachel Tan Hannah Penton Tianxin Pan Edward Webb
Read MoreThe 17th Joint Call for Proposals by the EuroQol Working Groups is now OPEN!
The 17th Joint Call for Proposals by the EuroQol Working Groups is now OPEN. You can download the Call for Proposals document here. The EuroQol Research Foundation is inviting applications for funding by its competitive research funding programs. The Foundation aims to serve the public interest by supporting scientific research and development of instruments which…
Read MoreOur Monthly Scientific Selection: January Publications on EuroQol Instruments
[1-31 January 2024] 1. Stenson K, Fecteau TE, O’Callaghan L, Bryden P, Mellor J, Wright J, Earl L, Thomas O, Iqbal H, Barlow S, Parvanta S. Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey. J Neurol. 2024 Jan 11. 2. Bailey C, Howell M, Raghunandan…
Read MoreData collection completed: Steering Group has signed off on the data quality
We are pleased to announce that data collection for the new UK EQ-5D-5L valuation study was completed on September 18, 2023. For this study, 1200 subjects were recruited in the UK, who were interviewed by videoconference or face-to-face. On November 14, 2023 a Steering Group meeting took place where reports on the complete data set…
Read MoreRenaming EQ-5D-Y into EQ-5D-Y-3L
Researchers at the EuroQol Group are developing a new 5-level version of the EQ-5D-Y instrument, called the EQ-5D-Y-5L. This new version is expected to be available to all users by the end of 2024. The existing version of the EQ-5D-Y will now be renamed the EQ-5D-Y-3L, to help differentiate between these two youth versions of…
Read MoreData collection has successfully started
After successfully completing a pilot phase of interviewer training and data collection at the end of 2022, we are pleased to announce that the first participant in the new UK EQ-5D-5L valuation study was interviewed on 29 January 2023. Interviewer data will be collected online and face-to-face, to allow as many people to participate as…
Read MoreStudy team co-investigators updated
The research team for the UK EQ-5D-5L valuation study has been updated. The lead investigator is Donna Rowen (School of Health and Related Research, University of Sheffield) and co-investigators are: This team has been carefully selected by the project’s Steering Group and will bring significant experience and expertise to the valuation study.
Read More